Dr. Andrew J Merritt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28 1/2 E Main St, Marcellus, NY 13108 Phone: 315-673-9926 Fax: 315-673-9465 |
John A Alley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28 1/2 E Main St, Marcellus, NY 13108 Phone: 315-673-9926 Fax: 315-673-9465 |
Ramon Berrios, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1/2 Orange St, Marcellus, NY 13108 Phone: 315-673-1529 Fax: 315-673-2434 |
News Archive
FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
Intelsius, a global manufacturer and distributor of environmentally sustainable, temperature-controlled and regulatory-compliant packaging solutions, announces a strategic partnership with American Thermal Instruments (ATI), a leader in temperature monitoring, inspections and asset tracking.
An article published in the fall 2010 issue of CR, the AACR's magazine for cancer survivors and their families and caregivers, details the immense challenges faced by those who suffer with cancer and lack the necessary resources for proper treatment and care the homeless.
When one considers the risks of military service, skin cancer may not be top of mind. According to research published in the Journal of the American Academy of Dermatology, however, U.S. military personnel are more likely to develop skin cancer than the general population.
› Verified 9 days ago